CTSS and atherosclerosis: Cathepsin activatable, optical imaging agents based on cleavage of L-lysine sequences have been successfully applied in the characterization of atherosclerotic lesions in mouse and rabbit models of atherosclerosis and in the detection of cathepsin protease activity in human atherosclerotic plaques obtained at carotid endarterectomy [31–36].